About Apollo Hospitals' AICVD Cardiac Risk Assessment Tool

More than 60 per cent of disease and death in India is due to Non-Communicable Diseases (NCDs) like Cardiovascular Diseases. Cardiovascular Diseases also account for 45% of deaths in the 40-69 year age group. (*WHO Report - Sept 2017). Family history and various lifestyle factors have contributed to an increased risk of these diseases. The best way to beat cardiac diseases is to prevent them. It is important to understand and assess the risk factors to prevent Cardiovascular Diseases.

Apollo Hospital has developed the first ever AI-based, Cardio Vascular, Risk Assessment Tool (AICVD) for the early detection of heart disease. The Risk scoring tool is remarkable for its speed in processing data and its accuracy at predicting the probability of individual developing heart disease.

The tool enables the delivery of proactive, pre-emptive and preventive care for at-risk individuals improving lives

The tool is built using learning 5,00,000 patient records from Apollo, the AICVD algorithm predicts the 10-year-old risk of a person having a cardiac problem, such as heart attack or stroke, with almost 90% accuracy

Apollo Heart Institute Milestones

10000 +

Years of collective experience in Cardiac Care

2,00,000 +

Cardiac Surgeries performed till date

3,00,000 +

Angioplasties performed till date

Largest presence

with 37 hospitals across 20 cities in India

Largest robotic surgery

in India, 100 + Robotic Surgeries performed

India's First AI

driven Cardiac Risk Assessment Tool (AICVD)

About Apollo Heart Institutes

The Apollo story started with the heart. Apollo Heart Institutes pioneered open-heart surgeries and cardiac catheterization in India. Today, with its unmatched presence in 37 hospitals across 20 cities, Apollo Heart Institutes hold an unparalleled record of having performed than 2,00,000 heart surgeries and 3,00,000 angioplasties, leading the way in super-specialty cardiac care.

With the fastest door to needle time and the best infrastructure, the Apollo group remains the undisputed leader in Cardiac Care.

Enter Your Details to Start Free AI-CVD Risk Assessment

Start Your Free AI-CVD Risk Assessment now!